Search

everythinglearnresearchcommunity

for

Search:↓

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Ruxolitinib treatment may cause eyelash growth.

The research found that the gene activity in mouse skin stem cells changes significantly as they age.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

New research is helping develop better treatments for alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Eclipta alba may improve memory and help treat Alzheimer's disease.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

The pandemic caused new skin problems in children, mainly due to mask-wearing and stress.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Hair follicle regeneration possible, more research needed.

Bioactive molecules show promise for improving skin repair and regeneration by overcoming current challenges with further research.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.